NO143155C - Analogifremgangsmaate til fremstilling av terapeutisk aktive benzomorfaner. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive benzomorfaner.

Info

Publication number
NO143155C
NO143155C NO751371A NO751371A NO143155C NO 143155 C NO143155 C NO 143155C NO 751371 A NO751371 A NO 751371A NO 751371 A NO751371 A NO 751371A NO 143155 C NO143155 C NO 143155C
Authority
NO
Norway
Prior art keywords
benzomorphanes
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO751371A
Other languages
English (en)
Norwegian (no)
Other versions
NO143155B (no
NO751371L (de
Inventor
Thomas Alfred Montzka
John Daniel Matiskella
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO751371L publication Critical patent/NO751371L/no
Publication of NO143155B publication Critical patent/NO143155B/no
Publication of NO143155C publication Critical patent/NO143155C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO751371A 1974-04-18 1975-04-17 Analogifremgangsmaate til fremstilling av terapeutisk aktive benzomorfaner. NO143155C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46200774A 1974-04-18 1974-04-18

Publications (3)

Publication Number Publication Date
NO751371L NO751371L (de) 1975-10-21
NO143155B NO143155B (no) 1980-09-15
NO143155C true NO143155C (no) 1980-12-29

Family

ID=23834846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751371A NO143155C (no) 1974-04-18 1975-04-17 Analogifremgangsmaate til fremstilling av terapeutisk aktive benzomorfaner.

Country Status (23)

Country Link
JP (3) JPS6218552B2 (de)
BE (1) BE828054A (de)
CA (1) CA1040630A (de)
CH (1) CH623812A5 (de)
CS (1) CS199586B2 (de)
DD (1) DD119787A5 (de)
DE (1) DE2517220A1 (de)
DK (2) DK155999C (de)
FI (1) FI60564C (de)
FR (1) FR2267774B1 (de)
GB (1) GB1493420A (de)
HU (1) HU173039B (de)
IE (1) IE41003B1 (de)
IL (1) IL47114A (de)
LU (1) LU72315A1 (de)
NL (1) NL159971C (de)
NO (1) NO143155C (de)
OA (1) OA04983A (de)
PH (1) PH12067A (de)
SE (1) SE427181B (de)
SU (1) SU721002A3 (de)
YU (1) YU93275A (de)
ZA (1) ZA752471B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01179624A (ja) * 1988-01-12 1989-07-17 Matsushita Refrig Co Ltd 生鮮物貯蔵装置
GB2442535B (en) 2006-10-05 2011-07-13 Ngf Europ Ltd Method and articles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34235B1 (en) * 1969-06-04 1975-03-19 Acf Chemiefarma Nv 6,7-benzomorphans and their preparation

Also Published As

Publication number Publication date
JPS6127390B2 (de) 1986-06-25
HU173039B (hu) 1979-02-28
FR2267774B1 (de) 1978-08-04
IL47114A (en) 1979-01-31
FR2267774A1 (de) 1975-11-14
DK155999B (da) 1989-06-12
FI60564C (fi) 1982-02-10
ZA752471B (en) 1976-03-31
JPS50142568A (de) 1975-11-17
NO143155B (no) 1980-09-15
PH12067A (en) 1978-10-30
IE41003L (en) 1975-10-18
SE427181B (sv) 1983-03-14
OA04983A (fr) 1980-11-30
DE2517220A1 (de) 1975-11-06
CS199586B2 (en) 1980-07-31
JPS6218552B2 (de) 1987-04-23
JPS60120868A (ja) 1985-06-28
JPH0119387B2 (de) 1989-04-11
SE7504469L (sv) 1975-10-20
IE41003B1 (en) 1979-09-26
CA1040630A (en) 1978-10-17
NL7504648A (nl) 1975-10-21
AU8025875A (en) 1976-10-21
IL47114A0 (en) 1975-06-25
DK166375A (da) 1975-10-19
FI60564B (fi) 1981-10-30
DD119787A5 (de) 1976-05-12
NL159971C (nl) 1979-09-17
NO751371L (de) 1975-10-21
SU721002A3 (ru) 1980-03-05
DK155999C (da) 1989-11-06
DE2517220C2 (de) 1990-04-19
GB1493420A (en) 1977-11-30
DK194088D0 (da) 1988-04-08
FI751106A (de) 1975-10-19
LU72315A1 (de) 1976-03-17
BE828054A (fr) 1975-10-17
YU93275A (en) 1982-02-28
DK194088A (da) 1988-04-08
JPS60142964A (ja) 1985-07-29
CH623812A5 (en) 1981-06-30

Similar Documents

Publication Publication Date Title
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
SE7507896L (sv) Inplanterbar anordning for forfarande for tillverkning av densamma.
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO144455C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater.
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
NO153573C (no) Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner.
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO144704C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler